α-Lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity
- 26 November 1999
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 10 (17) , 3675-3680
- https://doi.org/10.1097/00001756-199911260-00039
Abstract
A single administration of 3,4-methylenedioxymetham-phetamine (MDMA, 20 mg/kg, i.p.), induced significant hyperthermia in rats and reduced 5-hydroxytryptamine (5-HT) content and [3H]paroxetine-labeled 5-HT transporter density in the frontal cortex, striatum and hippocampus by 40–60% 1 week later. MDMA treatment also increased glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampus. Repeated administration of the metabolic antioxidant α-lipoic acid (100 mg/kg, i.p., b.i.d. for 2 consecutive days) 30 min prior to MDMA did not prevent the acute hyperthermia induced by the drug; however, it fully prevented the serotonergic deficits and the changes in the glial response induced by MDMA. These results further support the hypothesis that free radical formation is responsible for MDMA-induced neurotoxicity.Keywords
This publication has 11 references indexed in Scilit:
- Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the RatJournal of Neuroscience, 1998
- Redox regulation of cell functions by α‐lipoate: biochemical and molecular aspectsBioFactors, 1998
- Neuroprotection by the Metabolic Antioxidant α-Lipoic AcidFree Radical Biology & Medicine, 1997
- The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramineMolecular Neurobiology, 1995
- The spin trap reagent α-phenyl-N-tert-butylnitrone prevents ‘ecstasy’-induced neurodegeneration of 5-hydroxytryptamine neuronesEuropean Journal of Pharmacology, 1995
- Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptorBrain Research, 1995
- Excitatory Amino Acids as a Final Common Pathway for Neurologic DisordersNew England Journal of Medicine, 1994
- Quantitative Features of Reactive Gliosis following Toxicant‐induced Damage of the CNSaAnnals of the New York Academy of Sciences, 1993
- Glial changes following an excitotoxic lesion in the CNS—II. AstrocytesNeuroscience, 1991
- Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminalsNeuroscience, 1981